# PD-1 Inhibitor Combined With 125I Seed Implantation for Hepatocellular Carcinoma's Extrahepatic Metastasis: Efficacy and Safety

> **NCT06991907** · NA · COMPLETED · sponsor: **Jiangxi Provincial Cancer Hospital** · enrollment: 80 (actual)

## Conditions studied

- HCC - Hepatocellular Carcinoma
- 125I Seeds Implantation

## Interventions

- **PROCEDURE:** 125I seed implantation
- **DRUG:** PD-1 Inhibitors

## Key facts

- **NCT ID:** NCT06991907
- **Lead sponsor:** Jiangxi Provincial Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-01
- **Primary completion:** 2025-03-19
- **Final completion:** 2025-03-20
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2025-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06991907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06991907, "PD-1 Inhibitor Combined With 125I Seed Implantation for Hepatocellular Carcinoma's Extrahepatic Metastasis: Efficacy and Safety". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06991907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*